Hongyuan Chen

Hongyuan Chen, Ph.D has extensive experience in the field of scientific research. From 2012 to 2015, Chen worked as a Postdoctoral Scholar at UC Irvine. In this role, they conducted research in an academic setting.

In 2015, Chen joined BroadPharm as a Scientist. At BroadPharm, they focused on developing novel bioconjugate reagents for use in ADC drug development, click chemistry tools, biolabeling, proteolysis targeting chimera (PROTAC), and pharmaceutical and biotech R&D. They also worked on the development of novel PEG linkers with various functional groups. Chen remained with BroadPharm until December 2019.

In 2020, Chen joined Cidara Therapeutics as a Senior Scientist. They contributed to the company as a Senior Scientist until at least 2022, and later advanced to the position of Senior Scientist II in 2023. Unfortunately, the specific end dates for their roles at Cidara Therapeutics are not provided.

Hongyuan Chen, Ph.D completed their education with a Doctor of Philosophy (Ph.D.) degree in Chemistry from the University of Canterbury, where they studied from 2007 to 2011. Afterward, they pursued further research in the field of Biochemistry as a Postdoctoral Fellow at UC Irvine from 2012 to 2015.